Our Management and Supervisory Boards are united in helping us go further for health

A qualified physicist, Britta Fuenfstueck has led the HARTMANN GROUP since January 1, 2019. The 47-year-old is responsible for corporate strategy, the transformation program office and the core segment of infection management with the Risk Prevention and Disinfection divisions. Britta Fuenfstueck's responsibilities also include the German domestic market, the Digital, Human Resources, Corporate Communications & Branding and Compliance departments, as well as the subsidiary Kneipp. On an interim basis, the CEO is also responsible for the areas of Finance, Controlling, Legal, Mergers & Acquisitions, Investor Relations, Internal Audit and Risk Management.

A bio-medical engineer by training, François Georgelin has been a Member of the Management Board since January 1, 2020. In this function, the 54-year-old is responsible for the core segment Wound Management, as well as the pharmacy and e-business distribution channels. Furthermore, he manages the market activities in the USA and Australia.

Michel Kuehn, an industrial engineer, is responsible for the core segment Incontinence Management. In addition, the 65-year-old is in charge of the strategic management and control of the operative business of the Western, Central and Eastern European markets, as well as the Strategic Pricing department.

In addition to Regulatory Affairs, Quality Management and IT, mechanical engineer Dr. Raymund Heinen is also responsible for Supply Chain, Purchasing, Real Estate, Lean Management in operations as well as Technical Service. Furthermore, the 61-yearold is also responsible for HARTMANN operations worldwide, the subsidiaries KOB and CMC, as well as the emerging markets in Asia, South America and Africa.